Takeda Biopharmaceuticals India Private Limited, a global biopharmaceutical leader, showcased its cutting-edge digital innovations at the G20 Health Working Group meeting held in Goa, India. The focus of the meeting was “Citizen-Centric Health Delivery Ecosystems for Universal Health Coverage leveraging Digital Health and Innovations,” where discussions centered on creating a digital health ecosystem, innovations in healthcare, technology aiding continuing care, and digital public health goods. Takeda’s participation in the event provided a platform to showcase their digital capabilities and explore potential collaborations with G20 member countries, special invitee countries, and relevant international organizations.
Takeda Biopharmaceuticals presented three innovative solutions at the G20 Health Working Group meeting, including MyPKFit, Synapse, and Athena. MyPKFit is an FDA-approved application that offers personalized and interactive prophylaxis treatment options. Synapse is a platform designed to enhance awareness and knowledge-sharing among healthcare professionals, engaging over 4000 healthcare professionals through scientific exchange and educational initiatives. The Athena App MVP is a digital health solution that empowers patients to easily track, understand, and communicate simple, robust measures of Quality of Life (QOL).
Ruchi Sogarwal, Head of Corporate Affairs, Takeda Biopharmaceutical India Pvt Ltd, emphasized the importance of digital innovations in healthcare, stating, “Digital innovations have transformed virtually every aspect of our lives, and healthcare is no exception. Our innovative solutions, MyPKFit, Synapse, and Athena, are aimed at improving patient outcomes and advancing healthcare access.” Takeda Biopharmaceuticals is committed to leveraging digital solutions to transform healthcare and empower healthcare professionals with the knowledge and tools necessary to make a positive impact on patients’ lives.
Takeda Biopharmaceuticals’ participation in the G20 Health Working Group meeting aligns with their commitment to meeting the unmet needs of patients by discovering and delivering life-transforming treatments and innovative solutions. Through their digital innovations, Takeda Biopharmaceuticals seeks to improve patient outcomes, advance healthcare access, and enhance standards of care, thereby optimizing patient benefits. With a focus on leveraging digital solutions to transform healthcare, Takeda Biopharmaceuticals aims to create a brighter future for patients and the healthcare ecosystem.